- Home
- OPFI vs STXS Comparison
OPFI vs STXS Comparison
Compare OPFI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPFI
- STXS
- Stock Information
- Founded
- OPFI 2009
- STXS 1990
- Country
- OPFI United States
- STXS United States
- Employees
- OPFI N/A
- STXS N/A
- Industry
- OPFI Finance: Consumer Services
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- OPFI Finance
- STXS Health Care
- Exchange
- OPFI Nasdaq
- STXS Nasdaq
- Market Cap
- OPFI 174.4M
- STXS 189.8M
- IPO Year
- OPFI N/A
- STXS 2004
- Fundamental
- Price
- OPFI $9.29
- STXS $2.12
- Analyst Decision
- OPFI Buy
- STXS Strong Buy
- Analyst Count
- OPFI 2
- STXS 2
- Target Price
- OPFI $7.50
- STXS $4.50
- AVG Volume (30 Days)
- OPFI 1.0M
- STXS 422.5K
- Earning Date
- OPFI 03-06-2025
- STXS 03-03-2025
- Dividend Yield
- OPFI N/A
- STXS N/A
- EPS Growth
- OPFI 775.86
- STXS N/A
- EPS
- OPFI 0.38
- STXS N/A
- Revenue
- OPFI $260,661,000.00
- STXS $25,143,000.00
- Revenue This Year
- OPFI N/A
- STXS $1.16
- Revenue Next Year
- OPFI $6.51
- STXS $55.65
- P/E Ratio
- OPFI $24.57
- STXS N/A
- Revenue Growth
- OPFI 23.85
- STXS N/A
- 52 Week Low
- OPFI $2.35
- STXS $1.66
- 52 Week High
- OPFI $9.48
- STXS $3.29
- Technical
- Relative Strength Index (RSI)
- OPFI 66.33
- STXS 43.74
- Support Level
- OPFI $6.81
- STXS $2.21
- Resistance Level
- OPFI $8.73
- STXS $2.72
- Average True Range (ATR)
- OPFI 0.66
- STXS 0.16
- MACD
- OPFI 0.09
- STXS -0.02
- Stochastic Oscillator
- OPFI 92.70
- STXS 10.37
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.